<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#4d67ad"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007682"/>
	<fontspec id="font2" size="9" family="Courier" color="#007682"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#000000"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="24" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font11" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font13" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font14" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font15" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font16" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font17" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font18" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font19" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="67" height="9" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title">Bio Med Central<a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="756" left="508" width="46" height="10" font="font4" id="p1_t2" reading_order_no="53" segment_no="25" tag_type="text">Page 1 of 6<a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t3" reading_order_no="54" segment_no="26" tag_type="text">(page number not for citation purposes)<a href="http://www.biomedcentral.com/">Central</a></text>
<text top="35" left="55" width="397" height="23" font="font6" id="p1_t4" reading_order_no="0" segment_no="0" tag_type="title">Clinical and Molecular Allergy</text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Open Access<i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="50" height="13" font="font8" id="p1_t6" reading_order_no="3" segment_no="3" tag_type="title">Research<b>Clinical and Molecular Allergy</b></text>
<text top="105" left="55" width="487" height="15" font="font9" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="title">CCR3, CCR5, CCR8 and CXCR3 expression in memory T helper<a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="123" left="55" width="499" height="15" font="font9" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="title">cells from allergic rhinitis patients, asymptomatically sensitized and</text>
<text top="141" left="55" width="137" height="15" font="font9" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="title">healthy individuals<b>CCR3, CCR5, CCR8 and CXCR3 expression in memory T helper </b></text>
<text top="158" left="55" width="315" height="14" font="font10" id="p1_t10" reading_order_no="7" segment_no="5" tag_type="text">Mille Holse, Kristian Assing and Lars K Poulsen*<b>cells from allergic rhinitis patients, asymptomatically sensitized and </b></text>
<text top="194" left="55" width="448" height="8" font="font11" id="p1_t11" reading_order_no="8" segment_no="6" tag_type="text">Address: Laboratory for Medical Allergology 7542, National University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark<b>healthy individuals</b></text>
<text top="208" left="55" width="437" height="8" font="font11" id="p1_t12" reading_order_no="9" segment_no="7" tag_type="text">Email: Mille Holse - mholse@yahoo.dk; Kristian Assing - kristian.assing@rh.hosp.dk; Lars K Poulsen* - lkpallgy@inet.uni2.dk</text>
<text top="220" left="55" width="92" height="8" font="font11" id="p1_t13" reading_order_no="10" segment_no="8" tag_type="text">* Corresponding author</text>
<text top="368" left="112" width="44" height="10" font="font12" id="p1_t14" reading_order_no="20" segment_no="16" tag_type="title">Abstract</text>
<text top="383" left="112" width="385" height="9" font="font13" id="p1_t15" reading_order_no="21" segment_no="17" tag_type="text">Background: Chemokine receptors have been suggested to be preferentially expressed on CD4+<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16623955">  </a></text>
<text top="394" left="112" width="386" height="9" font="font14" id="p1_t16" reading_order_no="22" segment_no="17" tag_type="text">T cells with CCR3 and CCR8 linked to the T helper (Th) 2 subset and CCR5 and CXCR3 to the<b>Abstract</b></text>
<text top="406" left="112" width="190" height="9" font="font14" id="p1_t17" reading_order_no="23" segment_no="17" tag_type="text">Th1 subset, however this remains controversial.<b>Background: </b></text>
<text top="423" left="112" width="386" height="9" font="font13" id="p1_t18" reading_order_no="24" segment_no="18" tag_type="text">Objective: Our aim was to compare the CCR3, CCR5, CCR8 and CXCR3 expression in memory</text>
<text top="435" left="112" width="288" height="9" font="font14" id="p1_t19" reading_order_no="25" segment_no="18" tag_type="text">Th cells from allergic, asymptomatically sensitized and healthy individuals.</text>
<text top="451" left="112" width="386" height="9" font="font13" id="p1_t20" reading_order_no="26" segment_no="19" tag_type="text">Methods: Peripheral blood mononuclear cells from 8 pollen allergic rhinitis patients, 10</text>
<text top="463" left="112" width="386" height="9" font="font14" id="p1_t21" reading_order_no="27" segment_no="19" tag_type="text">asymptomatically sensitized and 10 healthy individuals were stimulated for 7 days with allergen or<b>Objective: </b></text>
<text top="475" left="112" width="385" height="9" font="font14" id="p1_t22" reading_order_no="28" segment_no="19" tag_type="text">tetanus toxoid. CCR3, CCR5, CCR8, CXCR3, CD4 and CD45RO were detected by flow</text>
<text top="487" left="112" width="43" height="9" font="font14" id="p1_t23" reading_order_no="29" segment_no="19" tag_type="text">cytometry.</text>
<text top="503" left="112" width="386" height="9" font="font13" id="p1_t24" reading_order_no="30" segment_no="20" tag_type="text">Results: No differences in chemokine receptor expression were observed between the three<b>Methods: </b></text>
<text top="515" left="112" width="386" height="9" font="font14" id="p1_t25" reading_order_no="31" segment_no="20" tag_type="text">groups on day 0, and seven days of unstimulated culture did not change the expression. Both</text>
<text top="527" left="112" width="386" height="9" font="font14" id="p1_t26" reading_order_no="32" segment_no="20" tag_type="text">antigenic stimuli increased the chemokine receptor expression, tetanus toxoid being the most</text>
<text top="539" left="112" width="386" height="9" font="font14" id="p1_t27" reading_order_no="33" segment_no="20" tag_type="text">potent. No differences in percentage chemokine receptor positive memory Th cells were observed</text>
<text top="550" left="112" width="386" height="9" font="font14" id="p1_t28" reading_order_no="34" segment_no="20" tag_type="text">between the three groups on day 7. Only a change in MFI for CCR5 was significantly different</text>
<text top="562" left="112" width="265" height="9" font="font14" id="p1_t29" reading_order_no="35" segment_no="20" tag_type="text">between the three groups after allergen stimulation of the Th cells.<b>Results: </b></text>
<text top="579" left="112" width="385" height="9" font="font13" id="p1_t30" reading_order_no="36" segment_no="21" tag_type="text">Conclusion: We conclude that even though allergen and antigen induced increased chemokine</text>
<text top="591" left="112" width="386" height="9" font="font14" id="p1_t31" reading_order_no="37" segment_no="21" tag_type="text">receptor expression, no differences in profiles were  identified in memory Th cells from patient</text>
<text top="602" left="112" width="137" height="9" font="font14" id="p1_t32" reading_order_no="38" segment_no="21" tag_type="text">groups with different atopic status.</text>
<text top="652" left="55" width="63" height="10" font="font12" id="p1_t33" reading_order_no="39" segment_no="22" tag_type="title">Introduction</text>
<text top="663" left="55" width="241" height="9" font="font15" id="p1_t34" reading_order_no="40" segment_no="24" tag_type="text">The prevalence of allergy is increasing in the westernized</text>
<text top="675" left="55" width="241" height="9" font="font15" id="p1_t35" reading_order_no="41" segment_no="24" tag_type="text">part of the world with estimates suggesting that 20–30%</text>
<text top="687" left="55" width="241" height="9" font="font15" id="p1_t36" reading_order_no="42" segment_no="24" tag_type="text">of the population is affected [1]. However, unlike the reac-<b>Conclusion: </b></text>
<text top="698" left="55" width="241" height="9" font="font15" id="p1_t37" reading_order_no="43" segment_no="24" tag_type="text">tion of most IgE-sensitized individuals who upon re-expo-</text>
<text top="710" left="55" width="241" height="9" font="font15" id="p1_t38" reading_order_no="44" segment_no="24" tag_type="text">sure to the allergen develop symptoms due to activation</text>
<text top="722" left="55" width="241" height="9" font="font15" id="p1_t39" reading_order_no="45" segment_no="24" tag_type="text">and release of mediators from various immune cells,</text>
<text top="652" left="313" width="241" height="9" font="font15" id="p1_t40" reading_order_no="46" segment_no="23" tag_type="text">some individuals seem to exhibit an IgE positive pheno-<b>Introduction</b></text>
<text top="663" left="313" width="241" height="9" font="font15" id="p1_t41" reading_order_no="47" segment_no="23" tag_type="text">type without having any allergic symptoms. These indi-</text>
<text top="675" left="313" width="241" height="9" font="font15" id="p1_t42" reading_order_no="48" segment_no="23" tag_type="text">viduals have been described in the literature as</text>
<text top="687" left="313" width="241" height="9" font="font16" id="p1_t43" reading_order_no="49" segment_no="23" tag_type="text">asymptomatically sensitized and are phenotypically consid-<a href="">1</a>]. However, unlike the reac-</text>
<text top="698" left="313" width="241" height="9" font="font15" id="p1_t44" reading_order_no="50" segment_no="23" tag_type="text">ered to be a group between the allergic and the healthy</text>
<text top="710" left="313" width="241" height="9" font="font15" id="p1_t45" reading_order_no="51" segment_no="23" tag_type="text">individuals with an increased risk of developing allergy</text>
<text top="722" left="313" width="23" height="9" font="font15" id="p1_t46" reading_order_no="52" segment_no="23" tag_type="text">[2,3].</text>
<text top="262" left="55" width="79" height="7" font="font17" id="p1_t47" reading_order_no="11" segment_no="9" tag_type="text">Published: 19 April 2006</text>
<text top="277" left="55" width="121" height="7" font="font18" id="p1_t48" reading_order_no="12" segment_no="12" tag_type="text">Clinical and Molecular Allergy 2006, 4 :6</text>
<text top="277" left="185" width="88" height="7" font="font17" id="p1_t49" reading_order_no="13" segment_no="12" tag_type="text">doi:10.1186/1476-7961-4-6</text>
<text top="262" left="310" width="97" height="7" font="font17" id="p1_t50" reading_order_no="18" segment_no="10" tag_type="text">Received: 29 November 2005<i>asymptomatically sensitized </i></text>
<text top="272" left="310" width="79" height="7" font="font17" id="p1_t51" reading_order_no="19" segment_no="11" tag_type="text">Accepted: 19 April 2006</text>
<text top="291" left="55" width="269" height="7" font="font17" id="p1_t52" reading_order_no="14" segment_no="13" tag_type="text">This article is available from: http://www.clinicalmolecularallergy.com/content/4/1/6</text>
<text top="305" left="55" width="159" height="7" font="font17" id="p1_t53" reading_order_no="15" segment_no="14" tag_type="text">© 2006 Holse et al; licensee BioMed Central Ltd.</text>
<text top="315" left="55" width="492" height="7" font="font17" id="p1_t54" reading_order_no="16" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),<a href="">[2,3].</a></text>
<text top="324" left="55" width="400" height="7" font="font17" id="p1_t55" reading_order_no="17" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
